SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics, (Nasdaq:MBRX) will announce its third quarter 2008 earnings results on Thursday, November 6, 2008, after markets close. Following the earnings release, Metabasis will hold a conference call and live webcast at 4:30 p.m. Eastern Time to discuss financial and other business results. Dr. Paul Laikind, president and chief executive officer and Mr. Dan Milles, senior director of finance, will participate in the call. Dr. Mark Erion, executive vice president of research and development and chief scientific officer, will also be available to answer questions.
